Who owns Guardant Health (GH)? Superinvestor holders
9 superinvestors of the 157 tracked here hold Guardant Health (GH) in their latest 13F filing, with $1.9B between them. Eric Bannasch gives it the most weight: 7.43% of the reported portfolio.
Key facts
- Superinvestors holding it
- 9 of 157
- Biggest holder
- John Overdeck and David Siegel (founders), $546.4M
- Largest weight
- Eric Bannasch, 7.43%of their portfolio
- Combined value
- $1.9B
- Bought last quarter
- 5
- Sold last quarter
- 4
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Eric BannaschCadian Capital Management | 7.43% | $89.1M | 499.51K | ▼ Reduced 34% | −257.9K | Q3 2026 |
| 2 | Karthik SarmaSRS Investment Management | 1.74% | $184.9M | 1.04M | New | +1.04M | Q3 2026 |
| 3 | Cathie WoodARK Invest | 0.62% | $108.3M | 607.17K | ▲ Added 20% | +100.77K | Q3 2026 |
| 4 | TemasekTemasek Holdings | 0.52% | $188.7M | 1.06M | ▲ Added 3.3% | +33.79K | Q3 2026 |
| 5 | John Overdeck and David Siegel (founders)Two Sigma Investments | 0.40% | $546.4M | 3.06M | ▼ Reduced 18% | −655.75K | Q3 2026 |
| 6 | Baillie Gifford teamBaillie Gifford & Co | 0.29% | $306.3M | 1.72M | ▼ Reduced 25% | −567.17K | Q3 2026 |
| 7 | Andrew SpokesFarallon Capital Management | 0.26% | $49.9M | 279.7K | ▼ Reduced 13% | −42.5K | Q3 2026 |
| 8 | Steve CohenPoint72 Asset Management | 0.21% | $138.1M | 920.81K | ▲ Added 32% | +224.86K | Q2 2026 |
| 9 | Israel EnglanderMillennium Management | 0.16% | $243.4M | 1.62M | ▲ Added 76% | +701.08K | Q2 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 7 | 8.26M | $1.5B | 3 | 4 |
| Q2 2026 | 157 | 9 | 11.19M | $1.7B | 5 | 5 |
| Q1 2026 | 157 | 7 | 10.38M | $959.1M | 2 | 6 |
| Q4 2025 | 157 | 8 | 11.35M | $1.2B | 4 | 4 |
| Q3 2025 | 157 | 7 | 9.22M | $576.1M | 3 | 3 |
| Q2 2025 | 157 | 5 | 11.86M | $617.4M | 2 | 2 |
| Q1 2025 | 156 | 5 | 13.94M | $593.6M | 0 | 5 |
| Q4 2024 | 156 | 4 | 13.67M | $417.7M | 0 | 4 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| John Overdeck and David Siegel (founders) | 3.06M | 3.72M | 4.23M | 2.17M | — | — | 1.83M | — |
| Baillie Gifford team | 1.72M | 2.28M | 3.86M | 4.89M | 5.13M | 4.81M | 5.06M | 5.45M |
| Temasek | 1.06M | 1.02M | 985.57K | 1.04M | 1.04M | 1.04M | 1.04M | 1.56M |
| Karthik Sarma | 1.04M | — | — | — | — | — | — | — |
| Cathie Wood | 607.17K | 506.42K | 486.68K | 691.65K | 795.23K | 2.82M | 1.41M | 1.44M |
| Eric Bannasch | 499.51K | 757.39K | 779.65K | 922.63K | 2.14M | 3.18M | 4.6M | 5.22M |
| Andrew Spokes | 279.7K | 322.2K | 8K | 109K | 8K | 8K | — | — |
| Israel Englander | · | 1.62M | — | — | — | — | — | — |
| Steve Cohen | · | 920.81K | — | 1.5M | — | — | — | — |
| Polen Capital team | — | 34.37K | 34.73K | 19.67K | 17.27K | — | — | — |
| Robert Pitts | · | — | — | — | 87.15K | — | — | — |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own GH?
In their latest 13F filings: Eric Bannasch (7.43% of the portfolio, $89.1M), Karthik Sarma (1.74% of the portfolio, $184.9M), Cathie Wood (0.62% of the portfolio, $108.3M), Temasek (0.52% of the portfolio, $188.7M), John Overdeck and David Siegel (founders) (0.40% of the portfolio, $546.4M), Baillie Gifford team (0.29% of the portfolio, $306.3M), Andrew Spokes (0.26% of the portfolio, $49.9M), Steve Cohen (0.21% of the portfolio, $138.1M), and 1 more.
Who bought GH last quarter?
Karthik Sarma (new position), Cathie Wood (added 20%), Temasek (added 3.3%), Steve Cohen (added 32%), Israel Englander (added 76%). “Last quarter” is each investor's latest reported quarter.
Who sold GH last quarter?
Reduced: Eric Bannasch (34% fewer shares), John Overdeck and David Siegel (founders) (18% fewer shares), Baillie Gifford team (25% fewer shares), Andrew Spokes (13% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Guardant Health (GH)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/GH/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to GH by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.